Literature DB >> 3121735

In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma.

G H Wong1, J F Krowka, D P Stites, D V Goeddel.   

Abstract

Treatment of cells with tumor necrosis factor-alpha and interferon-gamma greatly reduces their susceptibility to infection with human immunodeficiency virus and suppresses the production of human immunodeficiency virus (HIV) mRNA, core protein p24, and infectious HIV. The combination treatment is cytotoxic for HIV-infected cells and reduces HIV RNA levels in chronically infected cells.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3121735

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


  35 in total

1.  Tumor necrosis factor alpha selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation.

Authors:  G H Wong; T McHugh; R Weber; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Relationships between hepatitis C virus replication and CXCL-8 production in vitro.

Authors:  Bon Chang A Koo; Paula McPoland; Jessica P Wagoner; Olivia J Kane; Volker Lohmann; Stephen J Polyak
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.

Authors:  Sheila M Keating; Elizabeth T Golub; Marek Nowicki; Mary Young; Kathryn Anastos; Howard Crystal; Mardge H Cohen; Jinbing Zhang; Ruth M Greenblatt; Seema Desai; Shiquan Wu; Alan L Landay; Stephen J Gange; Philip J Norris
Journal:  AIDS       Date:  2011-09-24       Impact factor: 4.177

4.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.

Authors:  Nilu Goonetilleke; Stephen Moore; Len Dally; Nicola Winstone; Inese Cebere; Abdul Mahmoud; Susana Pinheiro; Geraldine Gillespie; Denise Brown; Vanessa Loach; Joanna Roberts; Ana Guimaraes-Walker; Peter Hayes; Kelley Loughran; Carole Smith; Jan De Bont; Carl Verlinde; Danii Vooijs; Claudia Schmidt; Mark Boaz; Jill Gilmour; Pat Fast; Lucy Dorrell; Tomas Hanke; Andrew J McMichael
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.

Authors:  G Herbein; L J Montaner; S Gordon
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells.

Authors:  M D'Addario; A Roulston; M A Wainberg; J Hiscott
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro.

Authors:  H Van Campen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism.

Authors:  C M Walker; A L Erickson; F C Hsueh; J A Levy
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo.

Authors:  B D Pearce; M V Hobbs; T S McGraw; M J Buchmeier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.